# Repare Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/repare-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Montreal, Canada
- Website: www.reparerx.com
- Total disclosed funding: $151M
- Latest round: Series B (Sep 4, 2019)
- Investors on record: 10

## About

Founded in 2016 and based in Montreal, Canada, Repare Therapeutics Inc. operates as a medical company that develops therapeutics for the treatment of cancer.

## Funding rounds

- Series B, Sep 4, 2019, $83M — OrbiMed Advisors, Versant Ventures, Healthcare Royalty Partners, BDC Capital, MPM BioImpact, Redmile Group, BVF Partners, Fonds de solidarité FTQ Investissements, Logos Capital
- Series A, Jun 22, 2017, $68M — Versant Ventures, BDC Capital, MPM BioImpact, Bristol-Myers Squibb Company, Fonds de solidarité FTQ Investissements

## Investors

- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A, Series B
- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Series A, Series B
- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Series A, Series B
- Bristol-Myers Squibb Company — Series A
- Fonds de solidarité FTQ Investissements — Series A, Series B
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B
- Healthcare Royalty Partners (https://capitalatlas.ai/funds/healthcare-royalty-partners) — Series B
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series B
- BVF Partners (https://capitalatlas.ai/funds/bvf-partners) — Series B
- Logos Capital (https://capitalatlas.ai/funds/logos-capital) — Series B